Linking with the community
We want to highlight the fruitful collaborations in the cluster. In a new article series, we present members who have a cluster story to tell. This week, we meet LINK Medical.
Author Archive for: oslocancer
Entries by oslocancer
Novartis enters IMPRESS
Novartis joins the IMPRESS oncology study with six of its cancer medicines to treat up to one hundred patients.
New partners join precision medicine consortium
Five new partners have joined CONNECT.
Meet our new competence broker
Eva S. Dugstad is our new research and industry facilitator aka competence broker for Oslo-based companies.
